1575. Clinical Validation of a Novel ELISpot-based in vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in SOT and HSCT Immunocompromised Patients

BACKGROUND: Impaired cytomegalovirus (CMV)-specific cell-mediated immunity (CMV-CMI) is a major cause of uncontrolled CMV reactivation and associated complications in both solid-organ transplantation (SOT) and hematopoietic stem cell transplantation (HSCT). Reliably assessing CMV-CMI is desirable to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Banas, Bernhard, Steubl, Dominik, Renders, Lutz, Chittka, Dominik, Banas, Miriam, Wekerle, Thomas, Koch, Martina, Witzke, Oliver, Lindemann, Monika, Muehlfeld, Anja, Sommerer, Claudia, Habicht, Antja, Hugo, Christian, Huenig, Thomas, Mielke, Stephan, Schreder, Martin, Wagner, Eva, Teschner, Daniel, Klein, Stefan, Heidenreich, Daniela, Kreil, Sebastian, Schaefer-Eckart, Kerstin, Gaertner, Johannes, Verbeek, Mareike, Grass, Sandra, Wolschke, Christine, Janson, Dietlinde, Kobbe, Guido, Kondakci, Mustafa, Ditschkowski, Markus, Gromke, Tanja, Hilgendorf, Inken, Lilienfeld-Toal, Marie Von, Schmidt, Traudel, Rascle, Anne, Barabas, Sascha, Deml, Ludwig, Wagner, Ralf, Kraemer, Bernhard, Krueger, Bernd, Wolff, Daniel
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6252655/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1403
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares